Carlsbad, CA – According to filings with the U.S. Securities and Exchange Commission, ChromaCode is raising $37,792,492.00 in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Gregory Gosch played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About ChromaCode

ChromaCode is a molecular diagnostics company with a bioinformatics focus and pedigree from Illumina, Google[x], Luminex, and Caltech.  We leverage patented mathematical methods and algorithmic enhancements to enrich signal processing from the most popular life science instrumentation.  We are using this to extract new information on biochemistry reactions and substantially increase the performance capabilities of today’s gold-standard biochemical assays at a very low cost.

To learn more about ChromaCode, visit http://chromacode.com/

Contact:
Gregory Gosch, President and Chief Executive Officer
442-244-4370
ggosch@chromacode.com
https://www.linkedin.com/in/greg-gosch/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved